Healthcare Jan 08, 2021 09:36 AM (GMT+8) · EqualOcean
EUROHEALTH news on January 8, today, genesearch, which focuses on the high-throughput single-cell omics platform, announced the completion of a round of financing of over 100 million yuan. This round of financing is led by Boyuan capital, followed by Chende capital and acted as the exclusive financial consultant by Haoyue capital. This round of financing will help cause finding biology accelerate the further development of single cell sequencing platform products, improve the commercial layout of self-developed products in domestic scientific research fields, and promote the application of single cell sequencing technology and related data in clinical and drug development. Seeking biology focuses on the independent development and clinical transformation of high-throughput single-cell multi omics platform products, with seekone? High-throughput single-cell library building platform and seekpair? Immune single cell receptor antigen matching platform as the main R & D direction. Recently, seekone? Mm (microwell & magnetic beads) single cell transcriptome library kit has completed the batch comparative test, and the series of products have reached the international leading level in terms of main indicators. It has officially started commercial application, and launched the "seekone? Human single cell annotation baseline program" at the end of 2020.

This text is a result of machine translation.